FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048058082> ?p ?o ?g. }

• W2048058082 endingPage "180" @default.
• W2048058082 startingPage "176" @default.
• W2048058082 abstract "Objective Indoxyl sulfate (IS), a uremic toxin, is a risk factor for progression of chronic kidney disease (CKD). AST-120 reduces serum IS and delays the progression of CKD. This study aimed to examine whether AST-120 inhibits epithelial-to-mesenchymal transition (EMT) in the kidneys of CKD rats. Methods CKD rats were produced by 5/6 nephrectomy and were divided into 2 groups: (1) CKD rats and (2) AST-120-treated CKD rats at a dosage of 4 g/kg body weight/day. After 10 weeks, their kidneys were excised for histological and immunohistochemical analysis. EMT was evaluated by immunohistochemistry of zonula occludens (ZO-1), an epithelial marker, and alpha-smooth muscle actin (α-SMA), a mesenchymal marker. Interstitial fibrosis was evaluated by Masson’s trichrome staining. Results CKD rats showed reduced expression of ZO-1 and enhanced expression of α-SMA as compared with normal rats. Administration of AST-120 to CKD rats increased expression of ZO-1 and decreased expression of α-SMA as compared with CKD rats. Further, CKD rats showed enhanced extent of interstitial fibrosis as compared with normal rats, and administration of AST-120 to CKD rats ameliorated interstitial fibrosis. CKD rats showed increased serum level of IS as compared with normal rats, whereas administration of AST-120 to CKD rats decreased both serum and urine levels of IS. Conclusion We conclude that AST-120 ameliorated EMT and interstitial fibrosis in the kidneys of CKD rats, probably by alleviating IS overload on the kidneys. Indoxyl sulfate (IS), a uremic toxin, is a risk factor for progression of chronic kidney disease (CKD). AST-120 reduces serum IS and delays the progression of CKD. This study aimed to examine whether AST-120 inhibits epithelial-to-mesenchymal transition (EMT) in the kidneys of CKD rats. CKD rats were produced by 5/6 nephrectomy and were divided into 2 groups: (1) CKD rats and (2) AST-120-treated CKD rats at a dosage of 4 g/kg body weight/day. After 10 weeks, their kidneys were excised for histological and immunohistochemical analysis. EMT was evaluated by immunohistochemistry of zonula occludens (ZO-1), an epithelial marker, and alpha-smooth muscle actin (α-SMA), a mesenchymal marker. Interstitial fibrosis was evaluated by Masson’s trichrome staining. CKD rats showed reduced expression of ZO-1 and enhanced expression of α-SMA as compared with normal rats. Administration of AST-120 to CKD rats increased expression of ZO-1 and decreased expression of α-SMA as compared with CKD rats. Further, CKD rats showed enhanced extent of interstitial fibrosis as compared with normal rats, and administration of AST-120 to CKD rats ameliorated interstitial fibrosis. CKD rats showed increased serum level of IS as compared with normal rats, whereas administration of AST-120 to CKD rats decreased both serum and urine levels of IS. We conclude that AST-120 ameliorated EMT and interstitial fibrosis in the kidneys of CKD rats, probably by alleviating IS overload on the kidneys." @default.
• W2048058082 created "2016-06-24" @default.
• W2048058082 creator A5035153820 @default.
• W2048058082 creator A5069679731 @default.
• W2048058082 creator A5091118320 @default.
• W2048058082 date "2012-01-01" @default.
• W2048058082 modified "2023-09-27" @default.
• W2048058082 title "AST-120 Ameliorates Epithelial-to-Mesenchymal Transition and Interstitial Fibrosis in the Kidneys of Chronic Kidney Disease Rats" @default.
• W2048058082 cites W1964177773 @default.
• W2048058082 cites W1972704071 @default.
• W2048058082 cites W1982670131 @default.
• W2048058082 cites W1997093408 @default.
• W2048058082 cites W2000204073 @default.
• W2048058082 cites W2003240711 @default.
• W2048058082 cites W2040487679 @default.
• W2048058082 cites W2042196358 @default.
• W2048058082 cites W2047561041 @default.
• W2048058082 cites W2049131515 @default.
• W2048058082 cites W2056498670 @default.
• W2048058082 cites W2068906486 @default.
• W2048058082 cites W2098915805 @default.
• W2048058082 cites W2102319255 @default.
• W2048058082 cites W2109083270 @default.
• W2048058082 cites W2124572189 @default.
• W2048058082 cites W2128368447 @default.
• W2048058082 cites W2129124145 @default.
• W2048058082 cites W2158862897 @default.
• W2048058082 cites W2160109224 @default.
• W2048058082 cites W2172120880 @default.
• W2048058082 cites W4211224216 @default.
• W2048058082 cites W4250731522 @default.
• W2048058082 doi "https://doi.org/10.1053/j.jrn.2011.10.015" @default.
• W2048058082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22200438" @default.
• W2048058082 hasPublicationYear "2012" @default.
• W2048058082 type Work @default.
• W2048058082 sameAs 2048058082 @default.
• W2048058082 citedByCount "38" @default.
• W2048058082 countsByYear W20480580822012 @default.
• W2048058082 countsByYear W20480580822013 @default.
• W2048058082 countsByYear W20480580822014 @default.
• W2048058082 countsByYear W20480580822015 @default.
• W2048058082 countsByYear W20480580822016 @default.
• W2048058082 countsByYear W20480580822017 @default.
• W2048058082 countsByYear W20480580822018 @default.
• W2048058082 countsByYear W20480580822020 @default.
• W2048058082 countsByYear W20480580822021 @default.
• W2048058082 countsByYear W20480580822022 @default.
• W2048058082 countsByYear W20480580822023 @default.
• W2048058082 crossrefType "journal-article" @default.
• W2048058082 hasAuthorship W2048058082A5035153820 @default.
• W2048058082 hasAuthorship W2048058082A5069679731 @default.
• W2048058082 hasAuthorship W2048058082A5091118320 @default.
• W2048058082 hasConcept C121608353 @default.
• W2048058082 hasConcept C126322002 @default.
• W2048058082 hasConcept C126894567 @default.
• W2048058082 hasConcept C134018914 @default.
• W2048058082 hasConcept C142724271 @default.
• W2048058082 hasConcept C163031210 @default.
• W2048058082 hasConcept C204232928 @default.
• W2048058082 hasConcept C2778653478 @default.
• W2048058082 hasConcept C2779013556 @default.
• W2048058082 hasConcept C2780091579 @default.
• W2048058082 hasConcept C2780559512 @default.
• W2048058082 hasConcept C71924100 @default.
• W2048058082 hasConcept C76419328 @default.
• W2048058082 hasConceptScore W2048058082C121608353 @default.
• W2048058082 hasConceptScore W2048058082C126322002 @default.
• W2048058082 hasConceptScore W2048058082C126894567 @default.
• W2048058082 hasConceptScore W2048058082C134018914 @default.
• W2048058082 hasConceptScore W2048058082C142724271 @default.
• W2048058082 hasConceptScore W2048058082C163031210 @default.
• W2048058082 hasConceptScore W2048058082C204232928 @default.
• W2048058082 hasConceptScore W2048058082C2778653478 @default.
• W2048058082 hasConceptScore W2048058082C2779013556 @default.
• W2048058082 hasConceptScore W2048058082C2780091579 @default.
• W2048058082 hasConceptScore W2048058082C2780559512 @default.
• W2048058082 hasConceptScore W2048058082C71924100 @default.
• W2048058082 hasConceptScore W2048058082C76419328 @default.
• W2048058082 hasIssue "1" @default.
• W2048058082 hasLocation W20480580821 @default.
• W2048058082 hasLocation W20480580822 @default.
• W2048058082 hasOpenAccess W2048058082 @default.
• W2048058082 hasPrimaryLocation W20480580821 @default.
• W2048058082 hasRelatedWork W2042033030 @default.
• W2048058082 hasRelatedWork W2048039626 @default.
• W2048058082 hasRelatedWork W2070511355 @default.
• W2048058082 hasRelatedWork W2082456910 @default.
• W2048058082 hasRelatedWork W2098742882 @default.
• W2048058082 hasRelatedWork W2127085070 @default.
• W2048058082 hasRelatedWork W2319873196 @default.
• W2048058082 hasRelatedWork W2328890399 @default.
• W2048058082 hasRelatedWork W2400445066 @default.
• W2048058082 hasRelatedWork W2042893290 @default.
• W2048058082 hasVolume "22" @default.
• W2048058082 isParatext "false" @default.
• W2048058082 isRetracted "false" @default.
• W2048058082 magId "2048058082" @default.
• W2048058082 workType "article" @default.